Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19

In patients with non-alcoholic fatty liver disease (NAFLD) with or without type 2 diabetes mellitus (T2DM), alpha-2 macroglobulin (A2M), apolipoprotein A1 (ApoA1), and haptoglobin are associated with the risk of liver fibrosis, inflammation (NASH), and COVID-19. We assessed if these associations wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Deckmyn, Olivier, Poynard, Thierry, Bedossa, Pierre, Paradis, Valérie, Peta, Valentina, Pais, Raluca, Ratziu, Vlad, Thabut, Dominique, Brzustowski, Angelique, Gautier, Jean-François, Cacoub, Patrice, Valla, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945355/
https://www.ncbi.nlm.nih.gov/pubmed/35327501
http://dx.doi.org/10.3390/biomedicines10030699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945355/
https://www.ncbi.nlm.nih.gov/pubmed/35327501
http://dx.doi.org/10.3390/biomedicines10030699

Ejemplares similares